Title

Ameloblastoma: An epidemiological perspective, with a focus on craniomaxillofacial reconstruction

Poster Number

34

Lead Author Affiliation

Dugoni School of Dentistry

Additional Authors

Miroslav Tolar

Introduction

Ameloblastoma, belonging to the family of epithelial odontogenic tumors, accounts for 1% of tumors and cysts in the jaw and 10% of all odontogenic tumors. Ameloblastoma is a benign, slowly growing, locally expanding epithelial odontogenic neoplasm that contains ameloblasts derived from dental lamina. In the majority of cases, it occurs in the mandible. Surgery is always a radical ectomy of the tumor including almost one cm of normal bone on both sides. From a craniomaxillofacial standpoint, the goal is to restore form and function of the mandibular apparatus while reestablishing functional relationships within the oral cavity to facilitate speech and deglutination and aesthetic appearance of the face.

Purpose

We review innovations pertaining to in vivo engineering of bone replacement that has aroused scholarly intellects of surgeons in an effort to achieve a more functional surgical result, decrease operative burden (morbidity) and to assemble a superior threedimensional outcome.

Method

Relevant recent articles were reviewed and the new information was combined with the previous knowledge.

Results

A racial proclivity towards African Americans has been noteworthy in regards to the occurrence of ameloblastoma. Exceptional innovation in tissue engineering has granted reconstructive surgeons a calculable outcome to restore form and function of the mandibular apparatus.

Significance

Ameloblastoma affects the bones of the maxillomandibular complex, representing the odontogenic tumor of high clinical significance. A racial penchant towards African Americans, in particular African American men, has overwhelmingly been reported in the research articles that have been reviewed. As for craniomaxillofacial reconstruction, advancement pertaining to in vivo engineering of bone replacement has revealed an opportunity for surgeons to formulate a more constructive surgical result, decrease operative burden (morbidity) and to contrive a superior three-dimensional outcome in comparison to conventional reconstruction techniques.

Location

DeRosa University Center, Stockton campus, University of the Pacific

Format

Poster Presentation

This document is currently not available here.

Share

COinS
 
Apr 25th, 2:00 PM Apr 25th, 4:00 PM

Ameloblastoma: An epidemiological perspective, with a focus on craniomaxillofacial reconstruction

DeRosa University Center, Stockton campus, University of the Pacific

Ameloblastoma, belonging to the family of epithelial odontogenic tumors, accounts for 1% of tumors and cysts in the jaw and 10% of all odontogenic tumors. Ameloblastoma is a benign, slowly growing, locally expanding epithelial odontogenic neoplasm that contains ameloblasts derived from dental lamina. In the majority of cases, it occurs in the mandible. Surgery is always a radical ectomy of the tumor including almost one cm of normal bone on both sides. From a craniomaxillofacial standpoint, the goal is to restore form and function of the mandibular apparatus while reestablishing functional relationships within the oral cavity to facilitate speech and deglutination and aesthetic appearance of the face.